BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 15491294)

  • 1. Aberrant somatic hypermutation in post-transplant lymphoproliferative disorders.
    Cerri M; Capello D; Muti G; Rambaldi A; Paulli M; Gloghini A; Berra E; Deambrogi C; Rossi D; Franceschetti S; Conconi A; Morra E; Pasqualucci L; Carbone A; Gaidano G
    Br J Haematol; 2004 Nov; 127(3):362-4. PubMed ID: 15491294
    [No Abstract]   [Full Text] [Related]  

  • 2. Genetic and phenotypic analysis of B-cell post-transplant lymphoproliferative disorders provides insights into disease biology.
    Vakiani E; Basso K; Klein U; Mansukhani MM; Narayan G; Smith PM; Murty VV; Dalla-Favera R; Pasqualucci L; Bhagat G
    Hematol Oncol; 2008 Dec; 26(4):199-211. PubMed ID: 18457340
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Post-transplant lymphoproliferative disorders: molecular basis of disease histogenesis and pathogenesis.
    Capello D; Rossi D; Gaidano G
    Hematol Oncol; 2005 Jun; 23(2):61-7. PubMed ID: 16216037
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular characterization of post-transplant lymphoproliferative disorders of donor origin occurring in liver transplant recipients.
    Capello D; Rasi S; Oreste P; Veronese S; Cerri M; Ravelli E; Rossi D; Minola E; Colosimo A; Gambacorta M; Muti G; Morra E; Gaidano G
    J Pathol; 2009 Aug; 218(4):478-86. PubMed ID: 19391128
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduced-intensity allogeneic haemopoietic stem cell transplantation induces durable responses in patients with chronic B-lymphoproliferative disorders.
    Hertzberg M; Grigg A; Gottlieb D; Szer J; Roberts A; Hoyt R; Huang G; Bradstock KF
    Bone Marrow Transplant; 2006 May; 37(10):923-8. PubMed ID: 16565735
    [TBL] [Abstract][Full Text] [Related]  

  • 6. B-cell posttransplant lymphoproliferative disorders in heart and/or lungs recipients: clinical and molecular-histogenetic study of 17 cases from a single institution.
    Lucioni M; Capello D; Riboni R; Ippoliti G; Campana C; Bandiera L; Arcaini L; Rossi D; Cerri M; Dionigi P; Lazzarino M; Magrini U; Viganò M; Gaidano G; Paulli M
    Transplantation; 2006 Oct; 82(8):1013-23. PubMed ID: 17060848
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prospective phase II trial of extended treatment with rituximab in patients with B-cell post-transplant lymphoproliferative disease.
    González-Barca E; Domingo-Domenech E; Capote FJ; Gómez-Codina J; Salar A; Bailen A; Ribera JM; López A; Briones J; Muñoz A; Encuentra M; de Sevilla AF; ; ;
    Haematologica; 2007 Nov; 92(11):1489-94. PubMed ID: 18024397
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Occurrence of post-transplant lymphoproliferative disorders among over thousand adult recipients: any role for hepatitis C infection?
    Burra P; Buda A; Livi U; Rigotti P; Zanus G; Calabrese F; Caforio A; Menin C; Canova D; Farinati F; Luciana Aversa SM
    Eur J Gastroenterol Hepatol; 2006 Oct; 18(10):1065-70. PubMed ID: 16957512
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Translocation (18;22)(q21;q11.2) in B-cell lymphoproliferative disorders: a report of six cases.
    Britos-Franco P; Rodríguez-Hernández I; Navarro JT; Granada I; Tapia G; Juncà J; Ribera JM; Millá F
    Leuk Lymphoma; 2015 Mar; 56(3):789-92. PubMed ID: 24884313
    [No Abstract]   [Full Text] [Related]  

  • 10. Identification of rare Epstein-Barr virus infected memory B cells and plasma cells in non-monomorphic post-transplant lymphoproliferative disorders and the signature of viral signaling.
    Shaknovich R; Basso K; Bhagat G; Mansukhani M; Hatzivassiliou G; Murty VV; Buettner M; Niedobitek G; Alobeid B; Cattoretti G
    Haematologica; 2006 Oct; 91(10):1313-20. PubMed ID: 17018379
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Methylation of c-myc gene changes in human lymphoproliferative diseases.
    Deguchi Y; Negoro S; Kishimoto S
    Biosci Rep; 1987 Aug; 7(8):637-43. PubMed ID: 3480763
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Post-transplant lymphoproliferative disorder with Hodgkin's lymphoma and large B-cell lymphoma differentiation.
    Novoa-Takara L; Dincer A; Kampalath B; Van Tuinen P; Hariharan S; Chang C
    Histopathology; 2005 Sep; 47(3):333-4. PubMed ID: 16115242
    [No Abstract]   [Full Text] [Related]  

  • 13. Impact of Epstein-Barr virus in monomorphic B-cell posttransplant lymphoproliferative disorders: a histogenetic study.
    Johnson LR; Nalesnik MA; Swerdlow SH
    Am J Surg Pathol; 2006 Dec; 30(12):1604-12. PubMed ID: 17122518
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Absence of the V617F JAK2 mutation in the lymphoid compartment in a patient with essential thrombocythemia and B-chronic lymphocytic leukemia and in two relatives with lymphoproliferative disorders.
    Musolino C; Allegra A; Penna G; Centorrino R; Cuzzola M; D'Angelo A; Iacopino P; Alonci A
    Acta Haematol; 2009; 122(1):46-9. PubMed ID: 19816006
    [TBL] [Abstract][Full Text] [Related]  

  • 15. B lymphocytes and Epstein-Barr virus: the lesson of post-transplant lymphoproliferative disorders.
    Dolcetti R
    Autoimmun Rev; 2007 Dec; 7(2):96-101. PubMed ID: 18035317
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular lesions in B-cell lymphoproliferative disorders: recent contributions from studies utilizing high-throughput sequencing techniques.
    Blombery PA; Dickinson M; Westerman DA
    Leuk Lymphoma; 2014 Jan; 55(1):19-30. PubMed ID: 23550993
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proteomics analysis in post-transplant lymphoproliferative disorders.
    Alsayed Y; Leleu X; Leontovich A; Oton AB; Melhem M; George D; Ghobrial IM
    Eur J Haematol; 2008 Oct; 81(4):298-303. PubMed ID: 18573174
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Trisomy 2 as the sole karyotypic abnormality in a lymphoproliferative disorder post-liver transplant.
    Ferro Delgado MT; Talavera M; Garcia-Miguel P; Sordo MT; Villalon C; Leon A; Garcia-Sagredo JM; San Roman C
    Cancer Genet Cytogenet; 2005 Dec; 163(2):184-5. PubMed ID: 16337866
    [No Abstract]   [Full Text] [Related]  

  • 19. Post-transplant lymphoproliferative disorder presenting as epistaxis.
    Clarke JD; Stock D; Singh V
    J Laryngol Otol; 2004 Nov; 118(11):906-8. PubMed ID: 15638984
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Slc11a1 (formerly Nramp1) polymorphisms and susceptibility to post-transplant lymphoproliferative disease following pediatric liver transplantation.
    Barshes NR; Lee TR; Goss JA; Goodpastor SE; Huls MH; Rooney CM; Karpen SJ; Wyllie S
    Transpl Infect Dis; 2006 Jun; 8(2):108-12. PubMed ID: 16734634
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.